A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent In Vitro, Ex Vivo, and In Vivo Antiviral Activity | |
Chong Huihui; Xue Jing; Xiong Shengwen; Cong Zhe; Ding Xiaohui; Zhu Yuanmei; Liu Zixuan; Chen Ting; Feng Yifan; He Lei | |
2017 | |
卷号 | 91期号:11 |
关键词 | HIV-1 HIV-2 fusion inhibitor lipopeptide |
ISSN号 | 0022-538X |
DOI | 10.1128/JVI.00288-17 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6367779 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Chong Huihui,Xue Jing,Xiong Shengwen,et al. A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent In Vitro, Ex Vivo, and In Vivo Antiviral Activity[J],2017,91(11). |
APA | Chong Huihui.,Xue Jing.,Xiong Shengwen.,Cong Zhe.,Ding Xiaohui.,...&He Yuxian.(2017).A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent In Vitro, Ex Vivo, and In Vivo Antiviral Activity.,91(11). |
MLA | Chong Huihui,et al."A Lipopeptide HIV-1/2 Fusion Inhibitor with Highly Potent In Vitro, Ex Vivo, and In Vivo Antiviral Activity".91.11(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论